sq-11725 has been researched along with Tachycardia, Ventricular in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (20.00) | 18.2507 |
2000's | 5 (25.00) | 29.6817 |
2010's | 8 (40.00) | 24.3611 |
2020's | 3 (15.00) | 2.80 |
Authors | Studies |
---|---|
Anastasakis, A; Bloise, R; Blom, NA; Davis, AM; Gambelli, P; Giordano, U; Keegan, R; Kukavica, D; Marino, M; Mazzanti, A; Memmi, M; Monserrat, L; Monteforte, N; Morini, M; Napolitano, C; Ortíz-Genga, M; Priori, SG; Santiago, DJ; Shimizu, W; Tomasi, L; Trancuccio, A | 1 |
Abrams, DJ; Przybylski, R | 1 |
Aziz, Z; Beaser, AD; Kohli, U; Nayak, HM | 2 |
Klug, D; Vaksmann, G | 1 |
Amoussou, M; Kambiré, Y; Konaté, L; Millogo, GR; Nebié, LV; Niakara, A; Sib, E | 1 |
Edvardsen, T; Haland, TF; Haugaa, KH; Leren, IS; Majid, E; Saberniak, J | 1 |
Tan, VH; Wong, KC; Yeo, C | 1 |
D'Angelo, L; Di Gesaro, G; Fazio, G; Fazio, M; Novo, G; Novo, S; Pipitone, S; Sutera, L; Vernuccio, D; Visconti, C | 1 |
DE Magalhaes, LP; Fagundes, A; Russo, M; Xavier, E | 1 |
Denjoy, I; Egéa, G; Guicheney, P; Lunardi, J; Roux-Buisson, N | 1 |
Brugada, P; Gebauer, R; Hindricks, G; Richter, S | 1 |
Acar, P; Delay, M; Dulac, Y | 1 |
Bloise, R; Chiaretti, A; De Rosa, G; Delogu, AB; Piastra, M; Priori, SG | 1 |
Lai, LP; Lin, JL; Lin, TK; Lin, YH | 1 |
Attali, P; Bing, J; Coron, T; Cuby, C; Gohard, R | 1 |
Massari, F; Mastropasqua, F; Passantino, A; Pitzalis, MV; Rizzon, P; Totaro, P | 1 |
Coumel, P; Denjoy, I; Grau, F; Leenhardt, A; Lucet, V; Ngoc, DD | 1 |
De Simone, L; Favilli, S; Fradella, G; Manetti, A; Pollini, I | 1 |
Alessi, SR; de Paola, AA; Leite, LR; Ponzi Pereira, KR | 1 |
1 review(s) available for sq-11725 and Tachycardia, Ventricular
Article | Year |
---|---|
Current management of inherited arrhythmia syndromes associated with the cardiac ryanodine receptor.
Topics: Adrenergic beta-Antagonists; Flecainide; Humans; Mutation; Nadolol; Ryanodine Receptor Calcium Release Channel; Tachycardia, Ventricular | 2023 |
19 other study(ies) available for sq-11725 and Tachycardia, Ventricular
Article | Year |
---|---|
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Child; Cohort Studies; Electrocardiography; Female; Humans; Male; Nadolol; Prospective Studies; Ryanodine Receptor Calcium Release Channel; Syncope; Tachycardia, Ventricular; Young Adult | 2022 |
Ventricular arrhythmia suppression with ivabradine in a patient with catecholaminergic polymorphic ventricular tachycardia refractory to nadolol, flecainide, and sympathectomy.
Topics: Adolescent; Cardiovascular Agents; Electrocardiography; Exercise Test; Flecainide; Humans; Ivabradine; Male; Nadolol; Phenotype; Sympathectomy; Tachycardia, Ventricular | 2020 |
Efficacy of ivabradine to control ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
Topics: Adolescent; Anti-Arrhythmia Agents; Cardiovascular Agents; Electrocardiography; Exercise Test; Female; Flecainide; Humans; Ivabradine; Male; Nadolol; Tachycardia, Ventricular; Young Adult | 2018 |
A large deletion in RYR2 exon 3 is associated with nadolol and flecainide refractory catecholaminergic polymorphic ventricular tachycardia.
Topics: Adolescent; Anti-Arrhythmia Agents; Exons; Flecainide; Gene Deletion; Humans; Male; Nadolol; Ryanodine Receptor Calcium Release Channel; Tachycardia, Ventricular | 2019 |
Right ventricular outflow tract tachycardia worsened during pregnancy.
Topics: Adult; Anti-Arrhythmia Agents; Catheter Ablation; Drug Therapy, Combination; Female; Flecainide; Hospitalization; Humans; Nadolol; Pregnancy; Pregnancy Complications, Cardiovascular; Tachycardia, Ventricular | 2015 |
Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Drug Monitoring; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Incidence; Male; Middle Aged; Nadolol; Norway; Ryanodine Receptor Calcium Release Channel; Severity of Illness Index; Tachycardia, Ventricular; Treatment Outcome | 2016 |
Exercise-induced syncope in a 22-year-old man.
Topics: Action Potentials; Anti-Arrhythmia Agents; DNA Mutational Analysis; Electrocardiography; Exercise; Exercise Test; Genetic Predisposition to Disease; Heart Conduction System; Heart Rate; Humans; Male; Mutation, Missense; Nadolol; Phenotype; Ryanodine Receptor Calcium Release Channel; Syncope; Tachycardia, Ventricular; Time Factors; Young Adult | 2017 |
Sympathetic tone and ventricular tachycardia.
Topics: Adolescent; Adrenergic beta-Antagonists; Child; Electrocardiography, Ambulatory; Heart Rate; Humans; Nadolol; Sympathetic Nervous System; Tachycardia, Ventricular | 2008 |
Pharmacological treatment of electrical storm in cathecolaminergic polymorphic ventricular tachycardia.
Topics: Adolescent; Anti-Arrhythmia Agents; Atenolol; Defibrillators, Implantable; Drug Therapy, Combination; Electrocardiography; Exercise Test; Humans; Male; Nadolol; Quality of Life; Syncope; Tachycardia, Ventricular; Verapamil | 2010 |
Germline and somatic mosaicism for a mutation of the ryanodine receptor type 2 gene: implication for genetic counselling and patient caring.
Topics: Anti-Arrhythmia Agents; Child; Combined Modality Therapy; Defibrillators, Implantable; Female; Genetic Counseling; Germ-Line Mutation; Humans; Male; Nadolol; Pedigree; Ryanodine Receptor Calcium Release Channel; Tachycardia, Ventricular; Treatment Outcome | 2011 |
A classic electrocardiographic manifestation of catecholaminergic polymorphic ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Child; DNA Mutational Analysis; Electrocardiography, Ambulatory; Female; Genetic Predisposition to Disease; Heart Conduction System; Humans; Mutation; Nadolol; Phenotype; Predictive Value of Tests; Ryanodine Receptor Calcium Release Channel; Tachycardia, Ventricular; Treatment Outcome | 2012 |
[Diagnosis of adrenergic ventricular tachycardia in two homozygotic twins].
Topics: Adrenergic beta-Antagonists; Child; Humans; Male; Nadolol; Receptors, Adrenergic; Tachycardia, Ventricular; Twins, Monozygotic | 2003 |
Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol.
Topics: Adrenergic beta-Antagonists; Brain Edema; Catecholamines; Child; Decerebrate State; Electrocardiography; Emergencies; Female; Humans; Infusions, Intravenous; Intensive Care Units, Pediatric; Nadolol; Propranolol; Ryanodine Receptor Calcium Release Channel; Syncope; Tachycardia, Ventricular; Ultrasonography | 2004 |
Exercise-provoked bidirectional ventricular tachycardia in a young woman.
Topics: Adolescent; Adrenergic beta-Antagonists; Exercise; Female; Humans; Nadolol; Tachycardia, Ventricular | 2004 |
[General anesthesia in a patient with catecholaminergic polymorph ventricular tachycardia].
Topics: Adult; Anesthesia, General; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Catecholamines; Electrocardiography, Ambulatory; Female; Humans; Monitoring, Intraoperative; Nadolol; Stress, Psychological; Tachycardia, Ventricular | 1995 |
The effect of nadolol on heart rate and the standard deviation of the RR intervals.
Topics: Adult; Aged; Electrocardiography; Electrocardiography, Ambulatory; Heart Rate; Humans; Middle Aged; Myocardial Contraction; Nadolol; Tachycardia, Ventricular; Ventricular Function, Left | 1995 |
Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.
Topics: Adrenergic beta-Antagonists; Child; Death, Sudden, Cardiac; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Long QT Syndrome; Male; Nadolol; Risk Factors; Syncope; Tachycardia, Ventricular; Time Factors | 1995 |
[Verapamil-responsive ventricular tachycardia in small children: a case report and review of the literature].
Topics: Anti-Arrhythmia Agents; Child, Preschool; Drug Therapy, Combination; Echocardiography, Doppler, Color; Electrocardiography; Female; Follow-Up Studies; Humans; Nadolol; Tachycardia, Ventricular; Time Factors; Verapamil | 1999 |
Catecholaminergic polymorphic ventricular tachycardia. An important diagnosis in children with syncope and normal heart.
Topics: Adrenergic beta-Antagonists; Child; Death, Sudden, Cardiac; Electrocardiography; Female; Follow-Up Studies; Humans; Nadolol; Syncope; Tachycardia, Ventricular | 2001 |